First Self-Administered Flu Vaccine For Home Use Gets FDA Approval

image via Medical Daily

September 23, 2024, 5:37 AM

• •The U.S. Food and Drug Administration (FDA) has approved the at-home use of nasal spray flu vaccine which can be self-administered without the help of a healthcare provider.
• •FluMist nasal spray manufactured by AstraZeneca is now approved for home use against influenza infection caused by subtypes A and B from ages 2 through 49.
• •The most common side effects of FluMist include fever over 100 degrees Fahrenheit in children ages 2-6, runny nose and nasal congestion in individuals ages 2-49, and sore throat in adults.

The U.S. Food and Drug Administration (FDA) has approved the at-home use of nasal spray flu vaccine which can be self-administered without the help of a healthcare provider. FluMist nasal spray manufactured by AstraZeneca is now approved for home use against influenza infection caused by subtypes A and B from ages 2 through 49. It was initially approved for prescription-based use in healthcare settings from 5 to 49 years of age in 2003. Later in 2007, the FDA approval included use in children from 2 through 5 years of age.

Read original article